About
Focal Biosciences develops a drug discovery platform combining chromatin fingerprint technology and AI to identify epigenetic modulators that reprogram cells, focusing primarily on treating and reversing fibrotic and other age-related chronic diseases.
Explore Focal Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.